Trial updates In thromboprophylaxis of cancer-related venous thromboembolism
The past decade has seen a large number of studies focusing on identifying cancer patients at high risk for venous...
Most Read
The role of microparticles in VTE
Cancer-associated venous thromboembolism (VTE) causes significant morbidity and mortality in patients and constitutes...
Arterial thromboembolism can also be the first clinical manifestation of a neoplasm
Several studies showed that venous thrombosis can be the first clinical manifestation of an occult neoplasm. For this...
NEW WEBINAR: September 27, 2021 – Clinical insights in CAT to include COVID‐19
Register at this link More information will come, stay...
Lessons from the CATCH study: beware of the risk of bleeding in neoplastic patients treated for VTE
The results of an interesting secondary analysis of the CATCH study were published recently and they are useful for a...
Awareness of venous thromboembolism risk in cancer patients: the oncologist knowledge gap
The management of cancer-associated venous thrombosis (CAT) is particularly challenging because of a high risk of major...
ISTH 2018 – Anna Falanga
Anna Falanga Chief of the Department of Immunohematology and Transfusion Medicine and the Thrombosis and Hemostasis...
An interview with Sam Schulman
Sam Schulman Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University,...
The conundrum of anti-angiogenesis in cancer
“Anti-angiogenesis in cancer is something of a conundrum where the unexpected is to be expected.”...